Painreform Research Development from 2010 to 2026

PRFX Stock  USD 0.98  0.15  13.27%   
Painreform Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, Painreform Research Development regression line of annual values had r-squared of  0.63 and arithmetic mean of  3,374,208. View All Fundamentals
 
Research Development  
First Reported
2017-12-31
Previous Quarter
139 K
Current Value
139 K
Quarterly Volatility
1.5 M
 
Covid
Check Painreform financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Painreform's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.7 K, Interest Expense of 12 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 40.93, Dividend Yield of 0.0 or PTB Ratio of 0.79. Painreform financial statements analysis is a perfect complement when working with Painreform Valuation or Volatility modules.
  
Build AI portfolio with Painreform Stock
Check out the analysis of Painreform Correlation against competitors.
For more information on how to buy Painreform Stock please use our How to Invest in Painreform guide.

Latest Painreform's Research Development Growth Pattern

Below is the plot of the Research Development of Painreform over the last few years. It is Painreform's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Painreform Research Development Regression Statistics

Arithmetic Mean3,374,208
Geometric Mean1,126,687
Coefficient Of Variation146.47
Mean Deviation3,868,882
Median504,000
Standard Deviation4,942,125
Sample Variance24.4T
Range14M
R-Value0.79
Mean Square Error9.7T
R-Squared0.63
Significance0.0001
Slope776,148
Total Sum of Squares390.8T

Painreform Research Development History

202614.1 M
202513.5 M
202411.7 M
2023M
20224.4 M
20212.9 M
2020354 K

About Painreform Financial Statements

Painreform investors use historical fundamental indicators, such as Painreform's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Painreform. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development13.5 M14.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Painreform Stock Analysis

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.